These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8067036)

  • 21. Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone.
    Arrizabalaga P; Montoliu J; Martinez Vea A; Andreu L; López Pedret J; Revert L
    Proc Eur Dial Transplant Assoc; 1983; 20():572-6. PubMed ID: 6318223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Parenteral administration of a new cephalosporin in patients with chronic kidney failure. Study of plasmatic half-life of the antibiotic in relation to glomerular clearance].
    Malandain H; Humbert G; Fillastre JP; Acar J; Dubois D; Leroy J; Robert M; Daufresne MF
    Pathol Biol (Paris); 1973 Mar; 21(3):233-9. PubMed ID: 4574486
    [No Abstract]   [Full Text] [Related]  

  • 24. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant.
    Sutherland WH; Corboy J; Walker RJ; Robertson MC; Ball MJ
    Nephrol Dial Transplant; 1995; 10(3):358-65. PubMed ID: 7792031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasmatic half-life of a new cephalosporin in a patient with chronic renal insufficiency].
    Humbert G; Malandain H; Acar J; Fillastre JP
    Nouv Presse Med; 1972 May; 1(21):1438. PubMed ID: 5036700
    [No Abstract]   [Full Text] [Related]  

  • 26. [Influence of hemodialysis on hormone levels in preterminal renal failure].
    Bindeballe W; Drenkhahn E; Jüsgen W; Lahrtz H; Leybold K; Niedermayer W; Schemmel K
    Dtsch Med Wochenschr; 1973 Mar; 98(13):661-5. PubMed ID: 4696493
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of ultraviolet irradiation of patients' blood on the morphofunctional status of erythrocytes].
    Cherniakov VL; Boĭkov AK; Vetchinnikova ON; Plaksina GV
    Ter Arkh; 1989; 61(9):118-20. PubMed ID: 2595570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc and copper concentration in plasma and erythrocytes of patients with chronic renal failure.
    Paniagua-Sierra JR; Pérez-López A; Diaz-Bensussen S; Solís-Alpuche L; Saavedra-Guatemala H; Exaire-Murad JE
    Arch Invest Med (Mex); 1981; 12(1):69-82. PubMed ID: 7247613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of iron overload in patients with renal failure.
    Tisher CC; Barnett BM; Finch CA; Scribner BH
    Clin Sci; 1967 Dec; 33(3):539-48. PubMed ID: 6078518
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sodium and potassium content of erythrocytes at the terminal stage of chronic renal insufficiency and during treatment by chronic hemodialysis].
    Terekhov NT; Goligorskiĭ MS; Kremen' MG; Vasilenko VK
    Urol Nefrol (Mosk); 1974; (6):10-4. PubMed ID: 4141153
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of glycemia in patients with diabetes mellitus and CKD.
    Lubowsky ND; Siegel R; Pittas AG
    Am J Kidney Dis; 2007 Nov; 50(5):865-79. PubMed ID: 17954300
    [No Abstract]   [Full Text] [Related]  

  • 32. Recombinant human erythropoietin in the diabetic patient.
    Friedman EA; Delano BG
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):35-9. PubMed ID: 2192415
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
    Broulík P; Hrubý M
    Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The efferent substitution correction of blood trace element disorder in patients with chronic kidney failure].
    Nykula TD; Krasiuk IV
    Lik Sprava; 1999; (7-8):102-4. PubMed ID: 10672705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The optimization of the treatment and timing of the intervention by a nephrologist in pre-dialytic chronic renal insufficiency].
    Sirignano C; D'Urso P; Di Iorio BR;
    G Ital Nefrol; 2003; 20(2):133-8. PubMed ID: 12746798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pyridoxine-HCl therapy on serum aminotransferase levels in haemodialysis patients.
    Demir K; Akyüz F; Aysuna N
    Nephrology (Carlton); 2006 Oct; 11(5):480. PubMed ID: 17014568
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tobramycin: pharmacology in man].
    Brogard JM; Harf C; Pinget M; Lavillaureix J
    Nouv Presse Med; 1974 Apr; 3(0):59-64. PubMed ID: 4600180
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of enterodesis in the complex treatment of patients with pronounced chronic renal failure].
    Del'machinskiĭ BV; Ermolenko VM; Lifshits NL; Suzdaleva VV; Makarova NL
    Ter Arkh; 1988; 60(8):89-91. PubMed ID: 3227485
    [No Abstract]   [Full Text] [Related]  

  • 40. [Indications for recombinant growth hormone (rhGH) treatment in kidney diseases].
    Colombo D; Ghio L; Marchesi F; Giani M; Carcano A; Consalvo G; Edefonti A
    Pediatr Med Chir; 1995; 17(1):17-22. PubMed ID: 7739921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.